Caricamento...
Voluntary warnings and the limits of good prescribing behavior: the case for de-adoption of meperidine
BACKGROUND: Meperidine (pethidine) offers little to no therapeutic advantage over other opioids, may be more prone to abuse, and produces a neurotoxic metabolite with a long half-life. The Institute for Safe Medication Practices (ISMP) issued warnings in 2004 and 2005 suggesting that meperidine be a...
Salvato in:
| Pubblicato in: | J Pain Res |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687958/ https://ncbi.nlm.nih.gov/pubmed/26719721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S96625 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|